← back to search
Christopher G. Dove
California Institute for Regenerative Medicine ·
Area of research
Biotechnology · Genetics
Research interest
Research interests include Biology, Reversion, Immunodeficiency, Germline mutation, Somatic cell, and SIGLEC.
h-index
—
citations
142
works
2
NIH funding
—
primary concept
—
email
✉ Find email ↗
Recent publications
MYC-driven synthesis of Siglec ligands is a glycoimmune checkpoint
Proceedings of the National Academy of Sciences
2023
cited by
63
position: middle
doi
Somatic reversion in dedicator of cytokinesis 8 immunodeficiency modulates disease phenotype
Journal of Allergy and Clinical Immunology
2014
cited by
79
position: middle
doi
Grants
No grants ingested yet.
Frequent collaborators
T. Prescott Atkinson
· University of Alabama at Birmingham
1
papers (2014–2014)
Carolyn R. Bertozzi
· Stanford University
1
papers (2023–2023)
Yu Zhang
· Kunming University of Science and Technology
1
papers (2014–2014)
Ashish Kumar
· Medical College of Wisconsin
1
papers (2014–2014)
Benjamin Smith
· University of Kentucky
1
papers (2023–2023)
David B. Lewis
· ENT and Allergy
1
papers (2014–2014)
Srividya Swaminathan
· City Of Hope National Medical Center
1
papers (2023–2023)
Helen Matthews
· Parkinson's UK
1
papers (2014–2014)
Jessica C. Stark
· Massachusetts Institute of Technology
1
papers (2023–2023)
Nicholas M. Riley
· University of Washington
1
papers (2023–2023)
John V. Pluvinage
· Arc Research Institute
1
papers (2023–2023)
Gülbû Uzel
· National Institutes of Health
1
papers (2014–2014)
Dean W. Felsher
· Stanford Health Care
1
papers (2023–2023)
Peter Mustillo
· The Ohio State University
1
papers (2014–2014)
Helen C. Su
· ActionAid
1
papers (2014–2014)
—
·
1
papers (2023–2023)
Erwin W. Gelfand
· University of Colorado Denver
1
papers (2014–2014)
Huie Jing
· National Institute of Allergy and Infectious Diseases
1
papers (2014–2014)
Daniel C. Douek
· Institut de Recherche Vaccinale
1
papers (2014–2014)
Anand Rajan
· Rutgers, The State University of New Jersey
1
papers (2023–2023)